$1.11
0.065.71%
Last update: Nov 11, 7:30 PM
Microbot Medical Inc
MBOTNASDAQ
Microbot Medical fell 46.9% from $2.09 to $1.11, behind the S&P 500's +11.2%. Its worst day was May 14 (−14.7%), and its low came Oct 21 at $0.94.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.07 missed the $-0.03 estimate on $0.00 revenue (est. $5.0M).
−6.1% · S&P 500 −1.7%
Story events cover the past 12 months · Times ET
Microbot Medical shares rose 21.8%, while the S&P 500 rose 0.7%.
+21.8% · S&P 500 +0.7%
Microbot Medical shares rose 11.4%, while the S&P 500 fell 0.3%.
+11.4%, on 21M shares, the year's heaviest volume · S&P 500 −0.3%
Microbot Medical stock jumps after Tampa General adopts its FDA-cleared LIBERTY robotic system ahead of April 2026 launch.
+23.9%, the year's best day · S&P 500 +0.7%
Microbot Medical closed at its highest level of the year, 36.4% above where the year started.
+13.1% · S&P 500 −0.1%
EPS of $-0.04 beat the $-0.06 estimate on $0.00 revenue (est. $180,000.00).
−8.8% · S&P 500 −1.7%
EPS of $-0.05 beat the $-0.07 estimate on $105,000.00 revenue (est. $490,000.00).
−14.7%, the year's worst day · S&P 500 +0.8%
Microbot Medical shares rose 12.9%, while the S&P 500 rose 0.6%.
+12.9% · S&P 500 +0.6%
EPS of $-0.08 beat the $-0.08 estimate on $241,000.00 revenue (est. $382,000.00).
−13.2% · S&P 500 −0.3%
Microbot Medical closed at its lowest level of the year, 55.0% below where the year started.
−0.8% · S&P 500 +0.5%
Where it ended: a close of $1.11 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.08, revenue est. $360,000.00).
Nothing in the past 12 months.
All MBOT dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MBOT and SPY from Benzinga historical bars. Not investment advice.
